Cell Therapy Manufacturing Market to be Worth USD 8 Billion by 2030, Predicts Roots Analysis

Cell Therapy Manufacturing Market to be Worth USD 8 Billion by 2030, Predicts Roots Analysis

PR Newswire

LONDON, November 14, 2018

LONDON, November 14, 2018 /PRNewswire/ --

Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market (2nd Edition), 2018-2030" report to its list of offerings.

     (Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg )

Natasha Thakur, the principal analyst, stated, "The growing number of cell therapy candidates continues to create an increasing demand for facilities that offer manufacturing services for these complex pharmacological interventions. Presently, over 145 companies / organizations are actively offering manufacturing services for such products. The installed global manufacturing capacity is estimated to be over 1 billion sq ft, with the maximum capacity available in North America"

The report presents opinions on several key aspects of the market. Among other elements, it includes:

The report features inputs from a number of eminent industry stakeholders. Thakur remarked, "Most of the experts we spoke to confirmed that the manufacturing of cell therapies is largely being outsourced due to exorbitant costs associated with setting-up such facilities." The report features detailed transcripts of discussions held with the following experts:

The research also includes detailed profiles of the following players:

For additional details, please visit 

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing-market-2nd-edition-2018-2030/209.html or email sales@rootsanalysis.com

Contact:
Gaurav Chaudhary
+1-604-595-4954
gaurav.chaudhary@rootsanalysis.com

Voltar noticias em Inglês